Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Breast Neoplasms 1

Interventions

Gemcitabine 19 130-nm albumin-bound paclitaxel 16 Specimen Handling 15 Irinotecan 11 Magnetic Resonance Spectroscopy 10 Fluorouracil 10 Leucovorin 9 Biopsy 9 Oxaliplatin 8 pembrolizumab 7 Cyclophosphamide 7 fludarabine 6 Cisplatin 5 Pemetrexed 4 Cetuximab 4 Albumin-Bound Paclitaxel 4 zimberelimab 3 trastuzumab deruxtecan 3 olaparib 3 irinotecan sucrosofate 3 durvalumab 3 dehydroftorafur 3 aldesleukin 3 Taxes 3 Radiosurgery 3 Nivolumab 3 Immunoglobulin G 3 Disulfides 3 Carboplatin 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Omeprazole × 30 days × Clear all

NCT04930991 2026-06-01

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡